Close

Jefferies Downgrades ISIS Pharmaceuticals (ISIS) Two-Notches to Underperform

July 19, 2012 7:18 AM EDT Send to a Friend
Jefferies downgraded ISIS Pharmaceuticals (NASDAQ: ISIS) from Buy to Underperform with a price target of $10.00.

The firm comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login